FLGT
Fulgent Genetics, Inc. · Healthcare · Market cap $595.2M
Insiders sold $117K net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 3, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$678K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 3, 2026
Gao Hanlin
Fulgent Genetics, Inc. (FLGT) has 51 SEC Form 4 filings (87 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 2 insiders at Fulgent Genetics, Inc. reported no open-market purchases and 15 open-market sales totaling $678K. The most active filer is President and COO Xie Jian with 8 filings. Insiders have net sold $223K over the trailing 6 months. The most recent open-market filing is a sale of 1,673 shares by Chief Scientific Officer Gao Hanlin, dated Sep 2, 2026, worth $33K.
- Industry:Medical - Diagnostics & Research
- CEO:Ming Hsieh
- Employees:1,315
- HQ:El Monte, CA, US
- IPO:2016-09-29
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 1,673 | $33K | Sep 3 | +10.1% | SEC ↗ | |
| President and COO | Sale | 2,127 | $42K | Sep 3 | +10.1% | SEC ↗ | |
| President and COO | Sale | 1,193 | $24K | Aug 28 | +10.3% | SEC ↗ | |
| Chief Scientific Officer | Sale | 939 | $19K | Aug 28 | +10.3% | SEC ↗ | |
| President and COO | Sale | 2,146 | $38K | Jun 3 | +19.2% | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,688 | $30K | Jun 3 | +19.2% | SEC ↗ | |
Xie JianFirst in 6 months | President and COO | Sale | 1,201 | $21K | May 28 | +18.6% | SEC ↗ |
Gao HanlinFirst in 6 months | Chief Scientific Officer | Sale | 945 | $17K | May 28 | +18.6% | SEC ↗ |
| Chief Scientific Officer | Sale | 1,075 | $30K | Dec 3 | -24.1% | SEC ↗ | |
| President and COO | Sale | 1,140 | $32K | Dec 3 | -24.1% | SEC ↗ | |
| Chief Scientific Officer | Sale | 943 | $28K | Dec 1 | — | SEC ↗ | |
| President and COO | Sale | 1,198 | $35K | Dec 1 | — | SEC ↗ | |
| President and COO | Sale | 681 | $21K | Nov 25 | — | SEC ↗ | |
Gao HanlinFirst filing | Chief Scientific Officer | Sale | 535 | $16K | Nov 25 | — | SEC ↗ |
Xie JianFirst filing | President and COO | Sale | 10,000 | $291K | Nov 21 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does FLGT have?
Fulgent Genetics, Inc. (FLGT) has 51 SEC Form 4 filings (87 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for FLGT?
The most recent Form 4 filing for FLGT on Tracefour is dated Sep 3, 2026.
Who is the most active insider at FLGT?
The most active SEC Form 4 filer at FLGT in the rolling window is President and COO Xie Jian, with 8 filings.
What is the net insider flow at FLGT over the last 6 months?
Over the trailing 180 days, insiders at FLGT have net sold $223K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at FLGT in the current window?
Inside the rolling window, insiders at FLGT bought $0 and sold $678K based on SEC Form 4 filings.
Can I get alerts for FLGT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Fulgent Genetics, Inc. (FLGT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Fulgent Genetics, Inc. is in the Healthcare sector.